News

Filter

Current filters:

Relpax

1 to 9 of 16 results

Multinational drugmakers raising awareness of illnesses in Japan

11-08-2003

In an effort to boost the sales of their own products, multinational pharmaceutical companies in Japan…

Eletriptan hydrobromideGlaxoSmithKlineGSKLamisilNovartisPfizerRelpaxTerbinafine

Almirall licenses triptan to Ortho-McNeil

28-04-2003

Spanish multinational drugmaker Almirall has granted a license toJohnson & Johnson's Ortho-McNeil Pharmaceutical…

AlmirallAlmotriptan MalateAxertEletriptan hydrobromidePfizerPharmaciaRelpax

Relpax cleared in USA after four-year review

06-01-2003

Pfizer's Relpax (eletriptan hydrobromide) has been approved in the USAfor the treatment of migraine headache…

AstraZenecaEletriptan hydrobromideFrovaFrovatriptan SuccinateGlaxoSmithKlineGSKMerck KGaAPfizerRelpaxUCB

Pfizer gets EU approval for Relpax

15-06-2001

Pfizer's migraine treatment Relpax (eletriptan hydrobromide), aselective 5-hydroxytryptamine receptor…

Eletriptan hydrobromidePfizerRelpax

World migraine therapy sales to 2009

14-11-2000

Sales of prescription drugs to treat migraine reached a level of around$1.9 million in 1999 in the world's…

AlmirallAlmotriptan MalateAxertEletriptan hydrobromideImitrexPfizerPharmaciaRelpaxSumatriptan Succinate

1 to 9 of 16 results

Back to top